Cargando…
How to measure (or not) compliance to eradication therapy
This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived bene...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166150/ https://www.ncbi.nlm.nih.gov/pubmed/25247005 |
_version_ | 1782335217231462400 |
---|---|
author | Martins, Ana Paula Ferreira, Ana Patrícia da Costa, Filipa Alves Cabrita, José |
author_facet | Martins, Ana Paula Ferreira, Ana Patrícia da Costa, Filipa Alves Cabrita, José |
author_sort | Martins, Ana Paula |
collection | PubMed |
description | This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients’ perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients’ normal behaviour. |
format | Online Article Text |
id | pubmed-4166150 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | Centro de Investigaciones y Publicaciones Farmaceuticas |
record_format | MEDLINE/PubMed |
spelling | pubmed-41661502014-09-22 How to measure (or not) compliance to eradication therapy Martins, Ana Paula Ferreira, Ana Patrícia da Costa, Filipa Alves Cabrita, José Pharm Pract (Granada) Original Research This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients’ perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients’ normal behaviour. Centro de Investigaciones y Publicaciones Farmaceuticas 2006 2006-07-31 /pmc/articles/PMC4166150/ /pubmed/25247005 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Martins, Ana Paula Ferreira, Ana Patrícia da Costa, Filipa Alves Cabrita, José How to measure (or not) compliance to eradication therapy |
title | How to measure (or not) compliance to eradication therapy |
title_full | How to measure (or not) compliance to eradication therapy |
title_fullStr | How to measure (or not) compliance to eradication therapy |
title_full_unstemmed | How to measure (or not) compliance to eradication therapy |
title_short | How to measure (or not) compliance to eradication therapy |
title_sort | how to measure (or not) compliance to eradication therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166150/ https://www.ncbi.nlm.nih.gov/pubmed/25247005 |
work_keys_str_mv | AT martinsanapaula howtomeasureornotcompliancetoeradicationtherapy AT ferreiraanapatricia howtomeasureornotcompliancetoeradicationtherapy AT dacostafilipaalves howtomeasureornotcompliancetoeradicationtherapy AT cabritajose howtomeasureornotcompliancetoeradicationtherapy |